The Latest in Multiple Sclerosis

Smoldering MS May Warrant Unique Diagnosis, Treatment, and Research Strategies

November 14, 2024

Multiple Sclerosis

sNFl and sGFAP Predict MS Disability in Unique Ways

October 3, 2024

Multiple Sclerosis

McDonald Criteria Update Aims to Simplify, Speed MS Diagnosis

September 25, 2024

Multiple Sclerosis

Genetically Driven Depression Tied to Increased MS Disease Activity

September 25, 2024

Multiple Sclerosis

Ofatumumab MS Study Supports Early Start Over Switch

September 25, 2024

Multiple Sclerosis

Novel Agent First to Slow Disability in Nonrelapsing Secondary MS

September 24, 2024

Multiple Sclerosis

No Signal of Benefit for Simvastatin in Progressive MS

September 23, 2024

Multiple Sclerosis

Disability Reduction Is a Twist in Negative BTKi RRMS Trial

September 23, 2024

Multiple Sclerosis

High-Dose Vitamin D Linked to Lower Disease Activity in CIS

September 20, 2024

Multiple Sclerosis

Positive Stem Cell Transplant Data Is Increasing Its Use

September 19, 2024

Multiple Sclerosis

Comorbidity Control Might Slow MS Activity

September 19, 2024

Multiple Sclerosis

FDA Okays Subcutaneous Ocrelizumab for MS

September 17, 2024

Multiple Sclerosis

Does MS Protect Against Alzheimer’s Disease?

September 9, 2024

Multiple Sclerosis

EMA Warns of Anaphylactic Reactions to MS Drug

July 15, 2024

Multiple Sclerosis

COMBAT-MS: Therapy Choice for Relapsing-Remitting MS Has ‘Small’ Impact on Disability Progression, Patient-Reported Outcomes

July 9, 2024

Multiple Sclerosis